In 2024, Fallouh Healthcare was awarded a £50,000 grant from the West Midlands Health Technologies Innovation Accelerator (WMHTIA) — a programme designed to fuel early-stage healthtech breakthroughs with real-world clinical potential.
This funding supported the development of the regulatory pathway for PerDeCT.— enabling us to reach key technical, regulatory, and clinical engagement milestones.
Key Outcomes of the WMHTIA-Funded Project:
- Prototype Development: Advanced and refined the early PerDeCT device to meet clinical needs.
- Clinical Co-Design: Collaborated with NHS clinicians to shape usability in real surgical settings.
- Regulatory Readiness: Laid the groundwork for a clear regulatory pathway, including early CE and FDA planning.
- Market Validation: Strengthened our case for downstream adoption with targeted clinical feedback.
This success directly contributed to Fallouh Healthcare securing a €900,000 Eureka award, further validating our vision and accelerating the journey toward clinical use.
“WMHTIA support gave us the early traction needed to turn a promising concept into a validated medical innovation — and helped unlock the next stage of scale-up funding.”